- Joined
- Apr 4, 2006
- Messages
- 2,684
- Reaction score
- 443
ampi-gent!!![]()
# of strains that are amp resistant and amp-gent sensitive?
ampi-gent!!![]()
No just discussing what you think is the best therapy. So if not linezolid, then?
Levaquin for prophy especially if we expect neutropenia. In most we otherwise prophy with acyclovir, fluc and SMX-TMP
Zosyn and vanco get a lot of work (and work for a lot of the patients)
Carbapenems are also quite popular choices as well.
Linezolid is reserved
Cubicin is used in maybe 1 patient a month?
does anyone know the price??
Jamaica?
Is an oral in development? Priced right, they could take a bunch of the market. We are under intense pressure to move folks out as soon as possible and an oral helps. Of course, our profit minded IDs will continue to have a PICC line placed and send them to their own infusion suite for vanc or dapto but for folks like me, I would like an oral option. Price too will be critical as will how quickly they can get on microscan. Our lab fights us over any manual requests outside of qc.
Dude this is IV...you call yourself an ID person?
are you serious? of course I know it's an IV right now. I clearly asked, if an oral was under development. Many patients admitted to our hospital are started on IV antibiotics then switched to equivalent oral therapy after clinical success or defervescence . Advantages of early IV to oral switch include: reduced cost, early discharge, less need for home IV therapy, virtual elimination of line infection. We regularly do this with doxy, minocycline, clindamycin, metronidazole, chloramphenicol, amox, trimethehoprim-sulfa, quinolones, and linezolid. We would love to do it with more cephalosporins but bioavalabilty issues have limited us. The delivery technology so far cannot provide an oral option for dapto, pip/tazo, ceftaz.
Sad that you call yourself a pharmacist. Glad you ain't licking any of my labels.
are you serious? of course I know it's an IV right now. I clearly asked, if an oral was under development. Many patients admitted to our hospital are started on IV antibiotics then switched to equivalent oral therapy after clinical success or defervescence . Advantages of early IV to oral switch include: reduced cost, early discharge, less need for home IV therapy, virtual elimination of line infection. We regularly do this with doxy, minocycline, clindamycin, metronidazole, chloramphenicol, amox, trimethehoprim-sulfa, quinolones, and linezolid. We would love to do it with more cephalosporins but bioavalabilty issues have limited us. The delivery technology so far cannot provide an oral option for dapto, pip/tazo, ceftaz.
Sad that you call yourself a pharmacist. Glad you ain't licking any of my labels.
Let me grab a tape measure so I can see who has the biggest internet ID specialist penis.
BRB.
I am a girl.
I would be interested in the gram negative spectrum. Right now we have approval for CAP, as it was compared to CTX in clinical trial. Does it have anti-pseudomonal activity, but not tested in trials? Obviously you worry about resistance with these super antbiotics, in if we are using it for just MRSA, are we inducing resistance to G-.... I think of tigecycline which was supposed to be the be all, end all antibiotic and did not live up to the hype.
5th generation...wow, I feel old.